RxSight, Inc. (RXST)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 23, 2026

Verified against EDGAR
Total Assets
$352.7M
Stockholders' Equity
$263.3M
Cash & Equivalents
$13.4M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, RxSight, Inc. reported revenue of $33.7M, net income of -$12.1M, and total assets of $352.7M. Every figure below is taken directly from RxSight, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2020–FY2025 · as reported

$139.9M$36.6M-$66.8M
FY2020FY2022FY2024FY2025
Revenue$134.5MNet income-$38.9M
FY2020 revenue
$14.7M
FY2025 revenue
$134.5M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$134.5M-$38.9M
FY2024$139.9M-$27.5M
FY2023$89.1M-$48.6M
FY2022$49.0M-$66.8M
FY2021$22.6M-$48.7M
FY2020$14.7M$27.6M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KAug 5, 2026on EDGAR ↗
10-QAug 5, 2026on EDGAR ↗
8-KJul 15, 2026on EDGAR ↗
8-KJul 6, 2026on EDGAR ↗
8-KJul 6, 2026on EDGAR ↗
8-KJun 16, 2026on EDGAR ↗
8-KMay 6, 2026on EDGAR ↗
10-QMay 6, 2026on EDGAR ↗
DEF 14AApr 28, 2026on EDGAR ↗
10-KFeb 25, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$352.7Msource ↗
Stockholders’ Equity$263.3Msource ↗
Cash & Equivalents$13.4Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$33.7Msource ↗
Net Income-$12.1Msource ↗
Operating Income-$13.8Msource ↗
Gross Profit$25.9Msource ↗
Cost of Revenue$7.9Msource ↗
R&D Expense$9.2Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.29source ↗
EPS (basic)$-0.29source ↗
Shares Outstanding41.6Msource ↗
Cash from Operations-$9.5Msource ↗
Cash from Financing$662,000source ↗
Cash from Investing$4.7Msource ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
0
Sells
4
Net shares
-16.9K

Restatement history

Point-in-time

No material restatements detected across 179 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches RXST’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/RXST

MCP tool: get_sec_fundamentals ticker=RXST

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/RXST/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=RXST as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/RXST/history

MCP tool: get_fundamentals_history ticker=RXST

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/RXST

MCP tool: get_financial_health ticker=RXST

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.